TREOSULFAN, FLUDARABINE AND ALEMTUZUMAB CONDITIONING FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH PRIMARY IMMUNODEFICIENCY: UK EXPERIENCE

被引：0
|
作者：
Slatter, M. [1 ]
Rao, K. [2 ]
Nademi, Z. [1 ]
Chiesa, R. [2 ]
Amrolia, P. [2 ]
Flood, T. [1 ]
Abinun, M. [1 ]
Cant, A. [1 ]
Hambleton, S. [1 ]
Allwood, Z. [2 ]
Skinner, R. [1 ]
Samarasinghe, S. [1 ]
Nikolajeva, O. [2 ]
Qasim, W. [2 ]
Gaspar, H. [2 ]
Gennery, A. [1 ]
Veys, P. [2 ]
机构：
[1] Newcastle Tyne NHS Fdn Trust, Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England
[2] Great Ormond St Hosp NHS Trust, London, England
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-O082
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [31] Treosulfan/fludarabine as conditioning regimen for allogeneic stem cell transplantation in multiple myeloma.
    Knauf, WU
    Blau, W
    Ruutu, T
    Einsele, H
    Thiel, E
    Freund, M
    Casper, J
    BLOOD, 2003, 102 (11) : 711A - 711A
  • [32] Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
    Remberger, Mats
    Torlen, Johan
    El Serafi, Ibrahim
    Garming-Legert, Karin
    Bjorklund, Andreas
    Ljungman, Per
    Sundin, Mikael
    Hassan, Moustapha
    Mattsson, Jonas
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (04) : 471 - 475
  • [33] Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
    Mats Remberger
    Johan Törlen
    Ibrahim El Serafi
    Karin Garming-Legert
    Andreas Björklund
    Per Ljungman
    Mikael Sundin
    Moustapha Hassan
    Jonas Mattsson
    International Journal of Hematology, 2017, 106 : 471 - 475
  • [34] Hematopoietic stem cell transplantation for children with primary immunodeficiency diseases: Single center experience in Jordan
    Amayiri, Nisreen
    Al-Zaben, Abdulhadi
    Ghatasheh, Lubna
    Frangoul, Haydar
    Hussein, Ayad Ahmed
    PEDIATRIC TRANSPLANTATION, 2013, 17 (04) : 394 - 402
  • [35] Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency
    Lum, S. H.
    Hoenig, M.
    Gennery, A. R.
    Slatter, M. A.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2019, 19 (11)
  • [36] Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency
    S. H. Lum
    M. Hoenig
    A. R. Gennery
    M. A. Slatter
    Current Allergy and Asthma Reports, 2019, 19
  • [37] Population Pharmacokinetics of Fludarabine and Treosulfan in Patients with Thalassemia Undergoing Hematopoietic Stem Cell Transplantation
    Mohanan, Ezhil Pavai
    Panetta, John C.
    Royan, Shareen Stella Backia
    Abraham, Ajay
    Edison, Eunice Sindhuvi
    Lakshmi, Kavitha M.
    Abubacker, Fouzia Nambiathayil
    Korula, Anu
    Abraham, Aby
    Viswabandya, Auro
    George, Biju
    Srivastava, Alok
    Mathews, Vikram
    Balasubramanian, Poonkuzhali
    BLOOD, 2015, 126 (23)
  • [38] Hematopoietic stem cell transplantation for primary immunodeficiency
    Alsaati, Nouf
    Grier, Alexandra
    Ochfeld, Elisa
    McClory, Susan
    Heimall, Jennifer
    ALLERGY AND ASTHMA PROCEEDINGS, 2024, 45 (05) : 371 - 383
  • [39] Treosulfan-based reduced-intensity hematopoietic stem cell transplantation in adults with primary immunodeficiency
    Via, V. Dalla
    Stelmes, A.
    Halter, J.
    Recher, M.
    Heim, D.
    Passweg, J.
    Medinger, M.
    van den Berg, J.
    SWISS MEDICAL WEEKLY, 2021, 151 : 30 - 30
  • [40] Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation
    Blau, I. W.
    Schmidt-Hieber, Martin
    Leschinger, N.
    Goeldner, H.
    Knauf, W.
    Hopfenmueller, W.
    Thiel, E.
    Blau, O.
    ANNALS OF HEMATOLOGY, 2007, 86 (08) : 583 - 589
12345